Gastroenterology

Colorectal Cancer

Questions discussed in this category

Would you offer chemoRT to a colon cancer case with a resected polyp with positive margins if the patient wishes to avoid surgery?

Would chemoRT be preferred over surgery if there is LVI or PNI?

3 Answers available

Would you treat an unresectable MSI-H colon cancer patient with persistent hepatitis C with immunotherapy?

1 Answer available

When do you perform HER2 testing in patients with colorectal cancer?

1 Answer available

When do you perform BRAF testing in colon cancer?

1 Answer available

Has pelvic MRI replaced EUS as the standard of care for rectal cancer staging?

Are there any indications to choose one over the other?

1 Answer available

Papers discussed in this category

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-03-10

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.

N Engl J Med,

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.

Nat Med, 2020 Apr 06

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023 Jan 09

Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors.

Related Topics in Gastroenterology